Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,001,535
+$2,859,050 QoQ
Shares Held
63,589
+5.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#712
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Wealth Partners, Ltd. holds $59,561,760 across 15 Drug Manufacturers - General names. ABBV ranks #3 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,389 | $18,458,029 | |
| 2 | AZN |
Astrazeneca PLC
|
88,890 | $16,855,321 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
63,589 | $16,001,535 | |
| 4 | AMGN |
Amgen Inc
|
12,495 | $4,524,689 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,974 | $1,667,159 | |
| 6 | JNJ |
Johnson & Johnson
|
5,276 | $1,339,945 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,957 | $285,622 | |
| 8 | NVS |
Novartis AG
|
1,133 | $177,563 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,001,535 | 63,589 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,142,485 | 60,428 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,297,432 | 58,197 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $12,234,110 | 52,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,848,505 | 47,670 | Shares | Sole | 2025-08-11 | |
| 2024-12-31 | $7,383,435 | 41,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,347,638 | 37,207 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $6,317,939 | 36,835 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $6,488,951 | 35,634 | Shares | Sole | 2024-05-20 | |
| 2023-12-31 | $5,065,659 | 32,688 | Shares | Sole | 2024-05-20 | |
| 2023-09-30 | $2,797,259 | 18,766 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $2,413,418 | 17,913 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $2,744,192 | 17,219 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,480,228 | 15,347 | Shares | Sole | 2023-04-24 | |
| 2022-09-30 | $1,853,440 | 13,810 | Shares | Sole | 2023-04-24 | |
| 2022-06-30 | $2,073,326 | 13,537 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $2,712,748 | 16,734 | Shares | Sole | 2022-05-19 | |
| 2021-12-31 | $1,996,608 | 14,746 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,542,541 | 14,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,240,616 | 11,014 | Shares | Sole | 2021-08-25 | |
| 2021-03-31 | $1,236,197 | 11,423 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $1,287,300 | 12,014 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $1,101,619 | 12,577 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,516,586 | 15,447 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,022,774 | 13,424 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||